SPG302 was well tolerated in a trial, with preliminary data supporting the idea the therapy might slow ALS progression.

After my husband, Todd, was diagnosed with ALS, I was shattered and desperate to connect with others who might understand the pain I was feeling.

Target ALS has released a short film about founder Dan Doctoroff’s mission to transform ALS research and bring hope to patients.

I was never a foodie. Never one to order the lobster gnocchi, a bone marrow rice bowl, or smoked mackerel wrapped in bacon. My preferences were always more pedestrian. Chicken nuggets and tater tots.

The Packard Center and ALS United will fund a preclinical study investigating how abnormal TDP-43 protein contributes to ALS.

Former Texas A&M football player Chris Larkin will lead the Aggieland Against ALS festival to raise funds for ALS research.

Columnist Kristin Neva compares how ALS affects various parts of your identity, whether you're a patient or a caregiver.

Columnist Dagmar Munn says her ALS diagnosis unexpectedly changed her mental clock. Every second of life became significant, she says.

A trial in Italy that's testing Avextra’s cannabis-based medicine for ALS and other neurodegenerative diseases enrolled its ...

People with ALS in the U.S. spend over $47,000 for medical care in the year after diagnosis, more than 3.5 times the average ...

Researchers developed a cell-free DNA blood test that accurately distinguishes ALS from other neurological diseases and tracks progression.

Amyotrophic lateral sclerosis (ALS) is more common in some parts of the U.S. than others, and it has a very strong geographic association with multiple sclerosis (MS), a new study suggests. The ...